학술논문
Tegafox, a new combination of UFT/LV and oxaliplatin as first-line treatment for patients (pts) with non resectable metastatic colorectal cancer (CRC): Results of a completed multicenter phase-II trial: 1088
Document Type
Academic Journal
Author
Source
Onkologie. Aug 01, 2003 26 Suppl 3:23-23
Subject
Language
English
ISSN
0378-584X